x

Search for a clinical trial

* (*) mandatory field

35 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member =

National clinical trial(s)

BELGIUM

ANTWERPEN
ANTWERPEN-EDEGEM

CZECH REPUBLIC

Capital City Prague
PRAHA

Ongoing trial
FIELD : A Study of Two Fabrazyme (agalsidase beta) Dosing Regimens in Treatment-naïve, Male Pediatric Patients Without Severe Symptoms (Phase IIIb) - CZ
First Faculty of Medicine and General Teaching Hospital
General Teaching Hospital and 1st Faculty of Medicine

FRANCE

ILE-DE-FRANCE
GARCHES

A 24-Week Safety and Pharmacodynamic Study of AT1001 in Patients With Fabry Disease (Phase II) - Terminated -
CHU Paris IdF Ouest - Hôpital Raymond Poincaré
Service de Génétique Médicale - Centre de référence Maladies Rares

FRANCE

ILE-DE-FRANCE
GARCHES

A 12-Week Safety and Pharmacodynamic Study of AT1001 in Female Patients With Fabry Disease (Phase II) - Terminated -
CHU Paris IdF Ouest - Hôpital Raymond Poincaré
Service de Génétique Médicale - Centre de référence Maladies Rares

FRANCE

ILE-DE-FRANCE
GARCHES

ITALY

LOMBARDIA
RANICA

Evaluation of the long term efficacy of enzyme replacement therapy in Fabry disease (CLOSED)
Istituto di Ricerche Farmacologiche Mario Negri
Laboratorio Documentazione e Ricerca sulle Malattie Rare

NETHERLANDS

Noord-Holland
AMSTERDAM

POLAND

Warszawa
WARSAW

POLAND

Warszawa
WARSAW

Multinational clinical trial(s)